Cerebrospinal fluid Aβ42/40 corresponds better than Aβ42 to amyloid PET in Alzheimer’s disease

Authors

Piotr Lewczuk, Universitätsklinikum Erlangen, and Friedrich-Alexander-Universität
Anja Matzen, IBL International GmbH
Kaj Blennow, Sahlgrenska Academy at the University of Gothenburg
Lucilla Parnetti, University of Perugia
Jose Luis Molinuevo, University of Barcelona
Paolo Eusebi, University of Perugia
Johannes Kornhuber, Universitätsklinikum Erlangen, and Friedrich-Alexander-Universität
John C. Morris, Washington University School of Medicine in St. Louis
Anne M. Fagan, Washington University School of Medicine in St. Louis

Journal

Journal of Alzheimer's Disease

Publication Date

2017

Volume

55

Issue

2

Inclusive Pages

813-822

Document Type

Open Access Publication

DOI

10.3233/JAD-160722

Rights and Permissions

Lewczuk P, Matzen A, Blennow K, Parnetti L, Molinuevo JL, Eusebi P, Kornhumber J, Morris JC, Fagan AM (2017) Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer’s Disease. Journal of Alzheimer's Disease, 55(2):813-822. DOI: 10.3233/JAD-160722 © 2017 – IOS Press and the authors. All rights reserved This article is published online with Open Access and distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC 4.0)

Recommended Citation

Lewczuk, Piotr; Matzen, Anja; Blennow, Kaj; Parnetti, Lucilla; Molinuevo, Jose Luis; Eusebi, Paolo; Kornhuber, Johannes; Morris, John C.; and Fagan, Anne M., "Cerebrospinal fluid Aβ42/40 corresponds better than Aβ42 to amyloid PET in Alzheimer’s disease." Journal of Alzheimer's Disease. 55, 2. 813-822. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/6725